Early Access — free while we kick the tires
EdgarHawk

Sarraf Pasha

Director

Director
1 filing analyzed · 1 company · Latest 2026-01-02

Companies

Company Buys Sells Direction
Cue Biopharma, Inc. CUE 5 0 Net buying

Activity

January 2026
2026-01-02 Cue Biopharma, Inc. CUE
high
Buy
323,857 shares
$99,747
Significance 7/10

Director Sarraf Pasha buys 323,857 shares at $0.31 blended avg (total $99,747.26) as CUE trades 80.7% below 52-week high.

Sarraf Pasha executed 5 separate purchases on 2025-12-30 totaling 323,857 shares for $99,747.26 at a blended average price of $0.31, bringing his holdings from 0 to 323,857 shares. The timing is notable: CUE's stock is trading at $10.12, which is -80.7% from the 52-week high of $52.50 and has declined -39.9% over the prior 30 days and -53.7% over the prior 90 days. The company faces profitability challenges with net income of $-7,448,000 in the latest quarter despite revenue growth of +69.2% year-over-year, and holds a market cap of $796,825,888.32. This substantial new position by a director during a steep drawdown warrants attention to whether it reflects confidence in valuation at depressed levels or other factors driving the transaction.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access